Prevention of muscle wasting by CRISPR/Cas9-mediated disruption of myostatin in vivo

Yuda Wei; Yanhao Chen; Yan Qiu; Huan Zhao; Gaigai Liu; Yongxian Zhang; Qingyang Meng; Guohao Wu; Yixiong Chen; Xiaolong Cai; Hui Wang; Hao Ying; Bin Zhou; Mingyao Liu; Dali Li; Qiurong Ding

doi:10.1038/mt.2016.192

Prevention of muscle wasting by CRISPR/Cas9-mediated disruption of myostatin in vivo

Yuda Wei
, Yanhao Chen
, Yan Qiu
, Huan Zhao
, Gaigai Liu
, Yongxian Zhang
, Qingyang Meng
, Guohao Wu
, Yixiong Chen
, Xiaolong Cai
, Hui Wang
, Hao Ying
, Bin Zhou
, Mingyao Liu
, Dali Li
, Qiurong Ding^*

^*Corresponding author for this work

School of Life Sciences

Research output: Contribution to journal › Letter › peer-review

25 Scopus citations

Original language	English
Pages (from-to)	1889-1891
Number of pages	3
Journal	Molecular Therapy
Volume	24
Issue number	11
DOIs	https://doi.org/10.1038/mt.2016.192
State	Published - 1 Nov 2016

Access to Document

10.1038/mt.2016.192

Cite this

@article{b9a121f93c1f48f996cb713429bef88c,

title = "Prevention of muscle wasting by CRISPR/Cas9-mediated disruption of myostatin in vivo",

author = "Yuda Wei and Yanhao Chen and Yan Qiu and Huan Zhao and Gaigai Liu and Yongxian Zhang and Qingyang Meng and Guohao Wu and Yixiong Chen and Xiaolong Cai and Hui Wang and Hao Ying and Bin Zhou and Mingyao Liu and Dali Li and Qiurong Ding",

year = "2016",

month = nov,

day = "1",

doi = "10.1038/mt.2016.192",

language = "英语",

volume = "24",

pages = "1889--1891",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Cell Press",

number = "11",

}

TY - JOUR

T1 - Prevention of muscle wasting by CRISPR/Cas9-mediated disruption of myostatin in vivo

AU - Wei, Yuda

AU - Chen, Yanhao

AU - Qiu, Yan

AU - Zhao, Huan

AU - Liu, Gaigai

AU - Zhang, Yongxian

AU - Meng, Qingyang

AU - Wu, Guohao

AU - Chen, Yixiong

AU - Cai, Xiaolong

AU - Wang, Hui

AU - Ying, Hao

AU - Zhou, Bin

AU - Liu, Mingyao

AU - Li, Dali

AU - Ding, Qiurong

PY - 2016/11/1

Y1 - 2016/11/1

UR - https://www.scopus.com/pages/publications/85002942798

U2 - 10.1038/mt.2016.192

DO - 10.1038/mt.2016.192

M3 - 快报

C2 - 27916995

AN - SCOPUS:85002942798

SN - 1525-0016

VL - 24

SP - 1889

EP - 1891

JO - Molecular Therapy

JF - Molecular Therapy

IS - 11

ER -

Prevention of muscle wasting by CRISPR/Cas9-mediated disruption of myostatin in vivo

Access to Document

Other files and links

Cite this